Omeros Corp. buy tamam
Start price
21.12.17
/
50%
€17.58
Target price
01.01.19
€29.77
Performance (%)
-42.84%
End price
01.01.19
€10.05
Summary
This prediction ended on 01.01.19 with a price of €10.05. The BUY prediction by tamam for Omeros Corp. performed very badly with a performance of -42.84%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Omeros Corp. | -9.691% | -9.691% | -28.981% | 209.564% |
| iShares Core DAX® | 0.323% | 2.208% | 21.610% | 72.184% |
| iShares Nasdaq 100 | 0.145% | -0.987% | 5.603% | 112.977% |
| iShares Nikkei 225® | 0.091% | -1.421% | 12.897% | 46.571% |
| iShares S&P 500 | 0.371% | -0.469% | 3.470% | 68.947% |
Comments by tamam for this prediction
In the thread Omeros Corp. diskutieren
tamam stimmt der Buy-Einschätzung von marge zu
tamam stimmt am 21.12.2017 der Buy-Einschätzung von marge, aber mit dem Kursziel 33$ zu.
Überschrift: Orphan drug market support blockbuster potential for OMS721
(Laufzeit überschritten)